These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29680482)

  • 1. Nanocrystals for improved dermal drug delivery.
    Pelikh O; Stahr PL; Huang J; Gerst M; Scholz P; Dietrich H; Geisel N; Keck CM
    Eur J Pharm Biopharm; 2018 Jul; 128():170-178. PubMed ID: 29680482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystals of medium soluble actives--novel concept for improved dermal delivery and production strategy.
    Zhai X; Lademann J; Keck CM; Müller RH
    Int J Pharm; 2014 Aug; 470(1-2):141-50. PubMed ID: 24813782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. smartPearls - Novel physically stable amorphous delivery system for poorly soluble dermal actives.
    Müller RH; Hespeler D; Jin N; Pyo SM
    Int J Pharm; 2019 Jan; 555():314-321. PubMed ID: 30439490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair follicle targeting with curcumin nanocrystals: Influence of the formulation properties on the penetration efficacy.
    Pelikh O; Eckert RW; Pinnapireddy SR; Keck CM
    J Control Release; 2021 Jan; 329():598-613. PubMed ID: 33011240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Dermal and Transdermal Delivery of Curcumin with SmartFilms and Nanocrystals.
    Eckert RW; Wiemann S; Keck CM
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33804137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeation of curcumin nanocrystals: Effect of particle size, delivery vehicles, and permeation enhancer.
    Xiang H; Xu S; Zhang W; Li Y; Zhou Y; Miao X
    Colloids Surf B Biointerfaces; 2023 Apr; 224():113203. PubMed ID: 36791520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair Follicle Targeting and Dermal Drug Delivery with Curcumin Drug Nanocrystals-Essential Influence of Excipients.
    Pelikh O; Keck CM
    Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33238636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nanocrystals-Based Topical Drug Delivery System with Improved Dermal Penetration and Enhanced Treatment of Skin Diseases.
    Sun L; Xiang H; Ge C; Chen X; Zhang Q; Zhang Y; Miao X
    J Biomed Nanotechnol; 2021 Dec; 17(12):2319-2337. PubMed ID: 34974856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.
    Arce FA; Setiawan N; Campbell HR; Lu X; Nethercott MJ; Bummer P; Su Y; Marsac PJ
    Mol Pharm; 2020 Nov; 17(11):4125-4140. PubMed ID: 32965123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nile red nanosuspensions as investigative model to study the follicular targeting of drug nanocrystals.
    Corrias F; Schlich M; Sinico C; Pireddu R; Valenti D; Fadda AM; Marceddu S; Lai F
    Int J Pharm; 2017 May; 524(1-2):1-8. PubMed ID: 28336458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogels for dermal and transdermal drug delivery.
    Labie H; Blanzat M
    Biomater Sci; 2023 Jun; 11(12):4073-4093. PubMed ID: 37060109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application.
    Colombo M; Staufenbiel S; Rühl E; Bodmeier R
    Int J Pharm; 2017 Apr; 521(1-2):156-166. PubMed ID: 28223247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance study.
    Tomić I; Juretić M; Jug M; Pepić I; Cetina Čižmek B; Filipović-Grčić J
    Int J Pharm; 2019 May; 563():249-258. PubMed ID: 30965120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
    Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
    Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lutein nanocrystals as antioxidant formulation for oral and dermal delivery.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Nov; 420(1):141-6. PubMed ID: 21884768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical delivery of hexamidine.
    Parisi N; Paz-Alvarez M; Matts PJ; Lever R; Hadgraft J; Lane ME
    Int J Pharm; 2016 Jun; 506(1-2):332-9. PubMed ID: 27130367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel concept for the treatment of couperosis based on nanocrystals in combination with solid lipid nanoparticles (SLN).
    Pyo SM; Meinke M; Klein AF; Fischer TC; Müller RH
    Int J Pharm; 2016 Aug; 510(1):9-16. PubMed ID: 27265313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.